Published in Drug Week, May 13th, 2005
The legislation that passed the general assembly on April 11, House Bill 664, establishes the Maryland Biotechnology Investment Tax Credit Reserve Fund to provide tax credits to investors in early-stage biotechnology companies headquartered in Maryland.
"This legislation goes to the heart of what so many biotechnology companies need to advance to the next step--increased access to capital," said Julie Coons, president of the Tech Council of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.